541 related articles for article (PubMed ID: 21990111)
1. Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses.
Kousi M; Lehesjoki AE; Mole SE
Hum Mutat; 2012 Jan; 33(1):42-63. PubMed ID: 21990111
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses.
Kohan R; Cismondi IA; Oller-Ramirez AM; Guelbert N; Anzolini TV; Alonso G; Mole SE; de Kremer DR; de Halac NI
Curr Pharm Biotechnol; 2011 Jun; 12(6):867-83. PubMed ID: 21235444
[TBL] [Abstract][Full Text] [Related]
3. Current state of clinical and morphological features in human NCL.
Goebel HH; Wisniewski KE
Brain Pathol; 2004 Jan; 14(1):61-9. PubMed ID: 14997938
[TBL] [Abstract][Full Text] [Related]
4. A needle in a haystack? The impact of a targeted epilepsy gene panel in the identification of a treatable but rapidly progressive metabolic epilepsy: CLN2 disease.
Lourenço CM; Sallum JMF; Pereira AM; Girotto PN; Kok F; Vilela DRF; Barron E; Pessoa A; Oliveira BM
Arq Neuropsiquiatr; 2024 May; 82(5):1-8. PubMed ID: 38763144
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Molecular Characteristics of Neuronal Ceroid Lipofuscinosis in Saudi Arabia.
Saleh MM; Hamhom AM; Al-Otaibi A; AlGhamdi M; Housawi Y; Aljadhai YI; Alameer S; Almannai M; Jad LA; Alwadei AH; Tabassum S; Alsaman A; AlAsmari A; Al Mutairi F; Althiyab H; Bashiri FA; AlHumaidi S; Alfadhel M; Mink JW; AlHashim A; Faqeih EA;
Pediatr Neurol; 2024 Jun; 155():149-155. PubMed ID: 38653183
[TBL] [Abstract][Full Text] [Related]
6. Advances in the Treatment of Neuronal Ceroid Lipofuscinosis.
Rosenberg JB; Chen A; Kaminsky SM; Crystal RG; Sondhi D
Expert Opin Orphan Drugs; 2019; 7(11):473-500. PubMed ID: 33365208
[TBL] [Abstract][Full Text] [Related]
7. The gene mutated in variant late-infantile neuronal ceroid lipofuscinosis (CLN6) and in nclf mutant mice encodes a novel predicted transmembrane protein.
Wheeler RB; Sharp JD; Schultz RA; Joslin JM; Williams RE; Mole SE
Am J Hum Genet; 2002 Feb; 70(2):537-42. PubMed ID: 11727201
[TBL] [Abstract][Full Text] [Related]
8. Recognition and epileptology of protracted CLN3 disease.
Cameron JM; Damiano JA; Grinton B; Carney PW; McKelvie P; Silbert P; Lawn N; Scheffer IE; Oliver KL; Hildebrand MS; Berkovic SF
Epilepsia; 2023 Jul; 64(7):1833-1841. PubMed ID: 37039534
[TBL] [Abstract][Full Text] [Related]
9. Electroretinography data from ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinoses.
Russell KN; Mitchell NL; Wellby MP; Barrell GK; Palmer DN
Data Brief; 2021 Aug; 37():107188. PubMed ID: 34141843
[TBL] [Abstract][Full Text] [Related]
10. A
Imler E; Pyon JS; Kindelay S; Torvund M; Zhang YQ; Chandra SS; Zinsmaier KE
Elife; 2019 Oct; 8():. PubMed ID: 31663851
[TBL] [Abstract][Full Text] [Related]
11. Two compound heterozygous variants in the
Baltar F; Simoes C; Garagorry F; Graña M; Rodríguez S; Haydée Aunchayna M; Tapié A; Cerisola A; González G; Naya H; Spangenberg L; Raggio V
Front Pediatr; 2024; 12():1379254. PubMed ID: 38751748
[TBL] [Abstract][Full Text] [Related]
12. Targeting autophagy impairment improves the phenotype of a novel CLN8 zebrafish model.
Marchese M; Bernardi S; Ogi A; Licitra R; Silvi G; Mero S; Galatolo D; Gammaldi N; Doccini S; Ratto GM; Rapposelli S; Neuhauss SCF; Zang J; Rocchiccioli S; Michelucci E; Ceccherini E; Santorelli FM
Neurobiol Dis; 2024 Jul; 197():106536. PubMed ID: 38763444
[TBL] [Abstract][Full Text] [Related]
13. Intragenic MFSD8 duplication and histopathological findings in a rabbit with neuronal ceroid lipofuscinosis.
Christen M; Gregor KM; Böttcher-Künneke A; Lombardo MS; Baumgärtner W; Jagannathan V; Puff C; Leeb T
Anim Genet; 2024 May; ():. PubMed ID: 38712841
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic/Genotypic Profile of Children with Neuronal Ceroid Lipofuscinosis in Southern Brazil.
Santos BV; de Souza J; Zeny MS; Santos MLSF; do Valle DA
Neuropediatrics; 2024 Jun; ():. PubMed ID: 38857616
[TBL] [Abstract][Full Text] [Related]
15. RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease.
Xiong HY; Alipanahi B; Lee LJ; Bretschneider H; Merico D; Yuen RK; Hua Y; Gueroussov S; Najafabadi HS; Hughes TR; Morris Q; Barash Y; Krainer AR; Jojic N; Scherer SW; Blencowe BJ; Frey BJ
Science; 2015 Jan; 347(6218):1254806. PubMed ID: 25525159
[TBL] [Abstract][Full Text] [Related]
16. Free the data: one laboratory's approach to knowledge-based genomic variant classification and preparation for EMR integration of genomic data.
Bean LJ; Tinker SW; da Silva C; Hegde MR
Hum Mutat; 2013 Sep; 34(9):1183-8. PubMed ID: 23757202
[TBL] [Abstract][Full Text] [Related]
17. An informatics approach to analyzing the incidentalome.
Berg JS; Adams M; Nassar N; Bizon C; Lee K; Schmitt CP; Wilhelmsen KC; Evans JP
Genet Med; 2013 Jan; 15(1):36-44. PubMed ID: 22995991
[TBL] [Abstract][Full Text] [Related]
18. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Richards S; Aziz N; Bale S; Bick D; Das S; Gastier-Foster J; Grody WW; Hegde M; Lyon E; Spector E; Voelkerding K; Rehm HL;
Genet Med; 2015 May; 17(5):405-24. PubMed ID: 25741868
[TBL] [Abstract][Full Text] [Related]
19. Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing.
Bodian DL; McCutcheon JN; Kothiyal P; Huddleston KC; Iyer RK; Vockley JG; Niederhuber JE
PLoS One; 2014; 9(4):e94554. PubMed ID: 24728327
[TBL] [Abstract][Full Text] [Related]
20. Pathogenic variants for Mendelian and complex traits in exomes of 6,517 European and African Americans: implications for the return of incidental results.
Tabor HK; Auer PL; Jamal SM; Chong JX; Yu JH; Gordon AS; Graubert TA; O'Donnell CJ; Rich SS; Nickerson DA; ; Bamshad MJ
Am J Hum Genet; 2014 Aug; 95(2):183-93. PubMed ID: 25087612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
